Diabetes Drug Metformin Recalled for Cancer-Causing Ingredient

Throughout 2020, Metformin for type 2 diabetes has experienced multiple voluntary recalls from manufacturers. The latest involves two lots of extended-release formulas from Nostrum Laboratories. Testing indicates these products contain levels of nitrosamine N-Nitrosodimethylamine (NDMA) above the FDA’s Acceptable Daily Intake (ADI) limit of 96 ng/day.

Read More

Settlements Reached Ahead of First Opioids Trial

Hours before the first trial concerning the role of drug companies in the opioid epidemic, Teva Pharmaceuticals and three distributors settled for $260 million. Cuyahoga and Summit, two communities in Ohio, accused Teva – the world’s largest manufacturer of generic drugs – and distributors McKesson, Cardinal Health Inc. and AmerisourceBergen of making false, misleading claims that resulted in addiction and at least 400,000 fatalities.

Read More

FDA Updates Warning Label for Fluoroquinolones

Doctors have known about the serious side effects associated with Fluoroquinolones like Cipro, including tendon ruptures and neurological issues, for a number of years. In response, prescriptions have tapered off, except in the most extreme instances.

Read More

Latest Risperdal Case Developments: New Study, Start of Bellwether Trial, $2.2 Billion Settlement

With 900 pending Multi-District Litigation cases in Philadelphia, the first bellwether trial concerning Risperdal’s side effects started on Monday. The Nov. 3 trial (Re: Risperdal Litigation, Case No: 100300296, in the Philadelphia Court of Common Pleas) is the start of three to determine how the jury will respond. The second has been scheduled for January…

Read More

Risperdal’s Side Effects: Range and Severity

Risperdal, an atypical antipsychotic approved for treatment of bipolar disorder and schizophrenia in adults and autism and bipolar disorder in children, has been the subject of multiple lawsuits at the state level. Plaintiffs claim manufacturer Johnson & Johnson never provided sufficient warning about side effects, and stated false claims concerning risks in advertising. As well,…

Read More